Skip to main content
BioSyent Inc. (TSXV:RX)
Canada flag Canada · Delayed Price · Currency is CAD
14.50
-0.35 (-2.36%)
Apr 28, 2026, 3:46 PM EST

BioSyent Revenue

In the year 2025, BioSyent had annual revenue of 43.05M CAD with 22.90% growth. BioSyent had revenue of 9.67M in the quarter ending December 31, 2025, with 9.95% growth.

Revenue
43.05M
Revenue Growth
+22.90%
P/S Ratio
3.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
165.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202543.05M8.02M22.90%
Dec 31, 202435.03M3.44M10.89%
Dec 31, 202331.59M3.67M13.12%
Dec 31, 202227.93M-693.03K-2.42%
Dec 31, 202128.62M6.29M28.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cannara Biotech 113.01M
Charlotte's Web Holdings 68.41M
Ascend Wellness Holdings 686.36M
HLS Therapeutics 76.10M
Auxly Cannabis Group 151.48M
Grown Rogue International 44.46M
Medexus Pharmaceuticals 136.34M
Aurora Cannabis 373.12M
Revenue Rankings

BioSyent News

More News